Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Leases: 2019-2025

Historic Leases for Enanta Pharmaceuticals (ENTA) over the last 6 years, with Sep 2025 value amounting to $37.5 million.

  • Enanta Pharmaceuticals' Leases fell 7.65% to $37.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year decrease of 7.65%. This contributed to the annual value of $37.5 million for FY2025, which is 7.65% down from last year.
  • Enanta Pharmaceuticals' Leases amounted to $37.5 million in Q3 2025, which was down 1.83% from $38.2 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Leases high stood at $41.2 million for Q2 2024, and its period low was $4.7 million during Q3 2021.
  • Its 3-year average for Leases is $32.9 million, with a median of $37.5 million in 2025.
  • In the last 5 years, Enanta Pharmaceuticals' Leases tumbled by 32.89% in 2021 and then skyrocketed by 400.42% in 2022.
  • Enanta Pharmaceuticals' Leases (Quarterly) stood at $18.8 million in 2021, then grew by 24.99% to $23.5 million in 2022, then dropped by 9.33% to $21.3 million in 2023, then soared by 85.88% to $39.7 million in 2024, then fell by 7.65% to $37.5 million in 2025.
  • Its last three reported values are $37.5 million in Q3 2025, $38.2 million for Q2 2025, and $39.1 million during Q1 2025.